Denali Therapeutics (DNLI) Payables (2017 - 2026)
Denali Therapeutics (DNLI) reported Payables of $40.4 million for Q1 2026, up 377.42% year-over-year from $8.5 million in Q1 2025, and up 7896.04% quarter-over-quarter from $505000.0 in Q4 2025.
Denali Therapeutics (DNLI) Payables (2017 - 2026) Analysis & Trends
Denali Therapeutics (DNLI) has 10 years of Payables data on file, last reported at $40.4 million in Q1 2026.
- Payables for Q1 2026 came in at $40.4 million, up 377.42% year-over-year; the trailing twelve-month figure through Mar 2026 was $40.4 million (up 377.42% YoY), and the FY2025 annual result was $505000.0, down 95.47% from the prior year.
- Payables rose to $40.4 million in Q1 2026 per DNLI's latest filing, from $505000.0 in the prior quarter.
- Over five years, Payables peaked at $40.4 million in Q1 2026 and troughed at $505000.0 in Q4 2025.
- A 5-year average of $9.6 million and a median of $8.5 million in 2025 frame the typical range for Payables.
- The sharpest annual moves came in 2024 and 2025: Payables soared 435.21% in 2024, then sank 95.47% in 2025.
- A 5-year view of Payables shows it stood at $2.8 million in 2022, then jumped by 239.89% to $9.5 million in 2023, then grew by 17.44% to $11.1 million in 2024, then slumped by 95.47% to $505000.0 in 2025, then surged by 7896.04% to $40.4 million in 2026.
- Business Quant data shows DNLI's Payables at $40.4 million in Q1 2026, $505000.0 in Q4 2025, and $6.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 300,549.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 8.69 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 34.55 Mn |
| 10 | Denali Therapeutics | 4.35 Bn | 4.35 Bn | - | 40.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.38 Mn |
| Dec 31, 2025 | 505,000.00 |
| Sep 30, 2025 | 6.75 Mn |
| Jun 30, 2025 | 10.84 Mn |
| Mar 31, 2025 | 8.46 Mn |
| Dec 31, 2024 | 11.14 Mn |
| Sep 30, 2024 | 9.59 Mn |
| Jun 30, 2024 | 13.94 Mn |
| Mar 31, 2024 | 11.86 Mn |
| Dec 31, 2023 | 9.48 Mn |
| Sep 30, 2023 | 10.40 Mn |
| Jun 30, 2023 | 7.00 Mn |
| Mar 31, 2023 | 2.22 Mn |
| Dec 31, 2022 | 2.79 Mn |
| Sep 30, 2022 | 7.54 Mn |
| Jun 30, 2022 | 7.12 Mn |
| Mar 31, 2022 | 3.36 Mn |
| Dec 31, 2021 | 4.78 Mn |
| Sep 30, 2021 | 4.82 Mn |
| Jun 30, 2021 | 4.24 Mn |